Cargando…
The Fluctuation Trend of Serum Anti-SARS-CoV-2 IgM/IgG Antibodies Seroprevalence in the Non-COVID-19 Infected Population and Correlation with Peripheral Blood Leukocyte Parameters in Beijing, China, 2021: A Real-World Study
Since 2019, the coronavirus disease 2019 (COVID-19) global pandemic has caused more than 300 million cases of disease and 5 million deaths. Vaccination has been widely accepted as the most effective measure for the prevention and control of this disease. However, there is little understanding about...
Autores principales: | Wang, Pan, Yang, Nan, Xue, Yuting, Zhou, Jiansuo, Wu, Yonghua, Wang, Tiancheng, Cui, Liyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032992/ https://www.ncbi.nlm.nih.gov/pubmed/35455320 http://dx.doi.org/10.3390/vaccines10040571 |
Ejemplares similares
-
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021) -
Seroprevalence of CMV IgG and IgM in Korean women of childbearing age
por: Choi, Rihwa, et al.
Publicado: (2021) -
The seroprevalence of Mycoplasma pneumoniae IgM and IgG antibodies in patients with ischemic stroke
por: Roham, Maryam, et al.
Publicado: (2016) -
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
por: Borges, Lysandro Pinto, et al.
Publicado: (2020) -
Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey
por: Ibrahim, Saira, et al.
Publicado: (2016)